Uploaded image for project: 'eCQM Known Issues'
  1. eCQM Known Issues
  2. EKI-14

CMS127v10

    XMLWordPrintable

Details

    • EP/EC
    • Resolution: Unresolved
    • Moderate
    • None
    • Hide
      Implementers can map additional formulations of the pneumococcal conjugate vaccine, including pneumococcal conjugate vaccine 13 valent, pneumococcal conjugate vaccine 15 valent, and pneumococcal conjugate vaccine 20 valent, to the pneumococcal vaccine, unspecified formulation code (CVX code 109) in the Pneumococcal Polysaccharide 23 Vaccine (OID: 2.16.840.1.113883.3.464.1003.110.12.1089) value set.
      Show
      Implementers can map additional formulations of the pneumococcal conjugate vaccine, including pneumococcal conjugate vaccine 13 valent, pneumococcal conjugate vaccine 15 valent, and pneumococcal conjugate vaccine 20 valent, to the pneumococcal vaccine, unspecified formulation code (CVX code 109) in the Pneumococcal Polysaccharide 23 Vaccine (OID: 2.16.840.1.113883.3.464.1003.110.12.1089) value set.
    • 2022

    Description

      eCQM Impacted – CMS127v10 Pneumococcal Vaccination Status for Older Adults

      Issue – Measure includes only one code related to a specific formulation, PPSV23 pneumococcal vaccine formulation, to meet numerator requirements. This does not align with recently updated Advisory Committee on Immunization Practices guidelines.

      Attachments

        Activity

          People

            Unassigned Unassigned
            edave Mathematica EC eCQM Team
            Votes:
            2 Vote for this issue
            Watchers:
            10 Start watching this issue

            Dates

              Created:
              Updated: